Wacker Chemie (WCH) Investor presentation summary

Strategic focus and innovation

• Emphasis on customer focus, efficiency, and specialty products to drive growth and differentiation.

• Developed a new silane precursor for advanced memory chips and microprocessors, supporting cloud computing and AI applications.

• Four main business segments: Silicones, Polymers, Biosolutions, and Polysilicon, each with a leadership position in their respective markets.

Financial performance and outlook

• Achieved €6.4bn in sales and €824m EBITDA in 2023, with a 13% EBITDA margin.

• Q3 2024 sales declined 6% YoY to €1,430m, with EBITDA stable at €152m and a 10.6% margin.

• FY 2024 sales expected between €6.0–6.5bn, EBITDA in the €600–800m range, and net income substantially lower than last year.

Segment highlights

• Silicones: 8% YoY sales growth in Q3 2024, EBITDA more than doubled, margin rose to 15%.

• Polymers: Q3 2024 sales down 7% YoY, EBITDA down 38%, margin at 12.6%.

• Biosolutions: Q3 2024 sales up 29% YoY, EBITDA improved to €14m, margin at 13.7%.

• Polysilicon: Q3 2024 sales down 39% YoY, EBITDA down 36%, margin at 14%.